Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.

Even so, the lack of an increasing trend in the IRs observed during follow-up across PsO, PsA and axSpA populations supports that there is no association with events that require prolonged exposure or have a longer latency.

also in 63,971 other papers